RENAVIVE
RENAVIVE, licence 80092273: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Global Quality Health Inc.
- NPN or DIN-HM
- 80092273
- Status
- Active licence
- Licence date
- 17 May 2019
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Tribulus terrestris L.: Les parties de plantes doivent être cuites
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Phyllanthus niruri Source : Extrait de Feuille Extraction ratio : 10:1 Dry plant equivalent : 1000 mg | 100.0 mg | Not calculated |
| Crateva magna Source : Extrait d'écorce Extraction ratio : 10:1 Dry plant equivalent : 750 mg | 75.0 mg | Not calculated |
| Tribulus terrestris Source : Fruit extract Extraction ratio : 15:1 Dry plant equivalent : 3000 mg | 200.0 mg | Not calculated |
| Apium graveolens Source : Graine(s) | 20.0 mg | Not calculated |
| Boerhavia diffusa Source : Extrait de racine Extraction ratio : 8:1 Dry plant equivalent : 400 mg | 50.0 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Eau, cellulose, Dioxyde de silicium, Calcium phosphate dibasic, Acide stéarique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Sources of antioxdant(s)/Provides antioxidant(s). Source of antioxidant(s)/Provides antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Traditionally used in Ayurveda as Mutrala (diuretic). Traditionally used in Ayurveda as Vrsya (aphrodisiac) for men. Traditionally used in Ayurveda for relief of Mutrakrcchra (difficulty/painful urination). Traditionally used in Ayurveda for temporary relief of pain and discomfort associated with lower urinary tract infections.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80092273
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.